Insider Trading History of New Leaf Bpo Associates I, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by New Leaf Bpo Associates I, L.p. since 2017. The trader's CIK number is 1625693. At the time of the last reporting, New Leaf Bpo Associates I, L.p. was the 10% Owner of Deciphera Pharmaceuticals, Inc.. (stock ticker symbol DCPH). Also see all insider trading activities at Deciphera Pharmaceuticals, Inc..

Note that in the past New Leaf BPO Associates I, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Deciphera Pharmaceuticals, Inc. (DCPH) by New Leaf Bpo Associates I, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 DCPH 0 $0 350,000 $12,769,450 0 $0
2017 DCPH 375,000 $6,375,000 0 $0 0 $0

Yearly summary of insider trading at Aptinyx Inc. (APTX) by New Leaf Bpo Associates I, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 APTX 250,000 $4,000,000 0 $0 0 $0


Insider trading activities at 2 companies by New Leaf Bpo Associates I, L.p.:

1. Deciphera Pharmaceuticals, Inc. (DCPH)

2. Aptinyx Inc. (APTX)

Table 1. Insider trading of Deciphera Pharmaceuticals, Inc. (DCPH) by New Leaf Bpo Associates I, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-08-16 DCPH Sale 200,000 36.78 7,355,800
2019-08-15 DCPH Sale 150,000 36.09 5,413,650
2017-10-02 DCPH Buy 375,000 17.00 6,375,000

Table 2. Insider trading of Aptinyx Inc. (APTX) by New Leaf Bpo Associates I, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-06-25 APTX Buy 250,000 16.00 4,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by New Leaf Bpo Associates I, L.p. (10% Owner of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.